The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
To pursue a systematic approach to the discovery of functional connections among diseases, genetic perturbation, and drug action, we have created the first installment of a reference collection of gene-expression profiles from cultured human cells treated with bioactive small molecules, together with pattern-matching software to mine these data. We demonstrate that this “Connectivity Map” resource can be used to find connections among small molecules sharing a mechanism of action, chemicals and physiological processes, and diseases and drugs. These results indicate the feasibility of the approach and suggest the value of a large-scale community Connectivity Map project.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Notably, post-perturbation transcriptomics data are particularly suited for training computational models because the causal relationship between known perturbations (cause) and the measured post-perturbation gene expression (effect) allows for the modelling of mechanistic processes [11].”
From Benchmarking foundation cell models for post-perturbation RNA-seq prediction (2025) · cites this paper as [11]
In the citing paper
“Both Alakwaa’ and Luo’s pipelines use the CLUE platform, a cloud-based platform developed by the LINCS Center for signature-gene based drug ranking61.”
From ASGARD is a single-cell guided pipeline to aid repurposing of drugs (2023) · cites this paper as [61]
In the citing paper
“For example, in a classic paradigm inflammatory bowel disease (IBD) signatures were derived from surgical specimens and intersected with Connectivity Map70 data representing transcriptional readouts across a number of cell lines in response to treatment with many hundreds of drugs using a novel pattern-matching algorithm71. From this research the anticonvulsant drug topiramate was identified and”
From Exploiting machine learning for end-to-end drug discovery and development (2019) · cites this paper as [71]
In the citing paper
“Useful tools will include maps of evolutionary conservation (108) and chromatin state (140), as well as databases of cell-state signatures, such as genome-wide expression patterns, that may integrate aspects of cell biology under resting and provoked conditions (141).”
From Genetic Mapping in Human Disease (2008) · cites this paper as [141]
In the citing paper
“It has been shown that compounds eliciting similar transcriptional signatures tend to share mechanisms of action.170,207−209”
From Advancing Targeted Protein Degradation via Multiomics Profiling and Artificial Intelligence (2023) · cites this paper as [207]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Self-citationMolecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Golub, T. R., Slonim, D. K., Tamayo, P., Huard, C., Gaasenbeek, M., Mesirov, J. P., Coller, H., Loh, M. L., Downing, J. R., Caligiuri, M. A., et al. (1999) · Science · doi:10.1126/science.286.5439.531 · Cited by 11,516
Self-citationMootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Self-citationGene expression profiling predicts clinical outcome of breast cancer
van 't Veer, L. J., Dai, H., van de Vijver, M. J., He, Y. D., Hart, A. A. M., Mao, M., Peterse, H. L., van der Kooy, K., Marton, M. J., Witteveen, A. T., et al. (2002) · Nature · doi:10.1038/415530a · Cited by 9,536
Nonparametric Statistical Methods
(1999) · Technometrics · doi:10.1080/00401706.1999.10485954 · Cited by 6,090
Exploring the Metabolic and Genetic Control of Gene Expression on a Genomic Scale
DeRisi, J. L., Iyer, V. R., & Brown, P. O. (1997) · Science · doi:10.1126/science.278.5338.680 · Cited by 4,456
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
Forman, B. M., Tontonoz, P., Chen, J., Brun, R. P., Spiegelman, B. M., & Evans, R. M. (1995) · Cell · doi:10.1016/0092-8674(95)90193-0 · Cited by 2,858
Functional Discovery via a Compendium of Expression Profiles
Hughes, T. R., Marton, M. J., Jones, A. R., Roberts, C. J., Stoughton, R., Armour, C. D., Bennett, H. A., Coffey, E., Dai, H., He, Y. D., et al. (2000) · Cell · doi:10.1016/s0092-8674(00)00015-5 · Cited by 2,533
Research works printed but not linked: 7
- K. B. Glaser et al., Mol. Cancer Ther.2, 151 (2003).
- A. E. Wakeling, M. Dukes, J. Bowler, Cancer Res.51, 3867 (1991).
- J. Y. Vanderhoek, M. B. Feinstein, Mol. Pharmacol.16, 171 (1979).
- H. Hieronymus et al. Cancer Cell in press.
- Q. Yao et al., Clin. Cancer Res.9, 4483 (2003).
- T. Kubota et al., Cancer Res.58, 3344 (1998).
- G. Wei et al. Cancer Cell in press.
Cited by
Items 201–300 of 1,037
Dress, R. J., Dutertre, C.-A., Giladi, A., Schlitzer, A., Low, I., Shadan, N. B., Tay, A., Lum, J., Kairi, M. F. B. M., Hwang, Y. Y., et al. (2019) · Nature Immunology · doi:10.1038/s41590-019-0420-3 · Cited by 245
An analysis of human microbe–disease associations
Ma, W., Zhang, L., Zeng, P., Huang, C., Li, J., Geng, B., Yang, J., Kong, W., Zhou, X., & Cui, Q. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbw005 · Cited by 244
A single-sample microarray normalization method to facilitate personalized-medicine workflows
Piccolo, S. R., Sun, Y., Campbell, J. D., Lenburg, M. E., Bild, A. H., & Johnson, W. E. (2012) · Genomics · doi:10.1016/j.ygeno.2012.08.003 · Cited by 243
GSEA-InContext: identifying novel and common patterns in expression experiments
Powers, R. K., Goodspeed, A., Pielke-Lombardo, H., Tan, A.-C., & Costello, J. C. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty271 · Cited by 242
Drug Target Prediction and Repositioning Using an Integrated Network-Based Approach
Emig, D., Ivliev, A., Pustovalova, O., Lancashire, L., Bureeva, S., Nikolsky, Y., & Bessarabova, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0060618 · Cited by 241
“Connectivity Map, for instance, pioneered drug repositioning by comparing drug response expression with disease expression signatures [18,19].”
BackgroundDeep learning for drug response prediction in cancer
Baptista, D., Ferreira, P. G., & Rocha, M. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz171 · Cited by 237
Transcriptional data: a new gateway to drug repositioning?
Iorio, F., Rittman, T., Ge, H., Menden, M., & Saez-Rodriguez, J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.014 · Cited by 237
“…discovery and drug repositioning has been demonstrated already by its very first applications [36,37], and it highlights the potential of gene transcription profiling to serve as the common language to link chemistry, biology and the clinic, by inferring genome-wide similarities or differences [35].”
BackgroundMethodInfluentialNetwork-Based Methods for Prediction of Drug-Target Interactions
Wu, Z., Li, W., Liu, G., & Tang, Y. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01134 · Cited by 237
“…(Tatonetti et al., 2012; Kuhn et al., 2016), drug-indication associations (Brown and Patel, 2017), drug-induced gene expression profiles (Lamb et al., 2006; Subramanian et al., 2017), protein-protein interactions (Li et al., 2017), ADMET properties (Cheng et al., 2012a), clinical data…”
BackgroundApplications of Connectivity Map in drug discovery and development
Qu, X. A., & Rajpal, D. K. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.07.017 · Cited by 235
On the Integration of In Silico Drug Design Methods for Drug Repurposing
March-Vila, E., Pinzi, L., Sturm, N., Tinivella, A., Engkvist, O., Chen, H., & Rastelli, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00298 · Cited by 235
“One of the most comprehensive and systematic approaches toward leveraging the transcriptional signature approach for drug repositioning is the Connectivity Map project (Lamb et al., 2006).”
BackgroundDrug repositioning: Progress and challenges in drug discovery for various diseases
Hua, Y., Dai, X., Xu, Y., Xing, G., Liu, H., Lu, T., Chen, Y., & Zhang, Y. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114239 · Cited by 232
Chen, S., Liu, X., Peng, C., Tan, C., Sun, H., Liu, H., Zhang, Y., Wu, P., Cui, C., Liu, C., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.02.007 · Cited by 232
Pathogenesis and prevention of hepatitis C virus-induced hepatocellular carcinoma
Hoshida, Y., Fuchs, B. C., Bardeesy, N., Baumert, T. F., & Chung, R. T. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.07.010 · Cited by 230
Selective killing of K-ras mutant cancer cells by small molecule inducers of oxidative stress
Shaw, A. T., Winslow, M. M., Magendantz, M., Ouyang, C., Dowdle, J., Subramanian, A., Lewis, T. A., Maglathin, R. L., Tolliday, N., & Jacks, T. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105941108 · Cited by 230
Self-citationGenome-wide transcriptome profiling of homologous recombination DNA repair
Peng, G., Chun-Jen Lin, C., Mo, W., Dai, H., Park, Y.-Y., Kim, S. M., Peng, Y., Mo, Q., Siwko, S., Hu, R., et al. (2014) · Nature Communications · doi:10.1038/ncomms4361 · Cited by 229
Machine learning applications in drug development
Réda, C., Kaufmann, E., & Delahaye-Duriez, A. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.006 · Cited by 228
Ciallella, H. L., & Zhu, H. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.8b00393 · Cited by 227
Coulouarn, C., Corlu, A., Glaise, D., Guénon, I., Thorgeirsson, S. S., & Clément, B. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3317 · Cited by 224
The road to precision psychiatry: translating genetics into disease mechanisms
Gandal, M. J., Leppa, V., Won, H., Parikshak, N. N., & Geschwind, D. H. (2016) · Nature Neuroscience · doi:10.1038/nn.4409 · Cited by 223
Martin, D. N., Boersma, B. J., Yi, M., Reimers, M., Howe, T. M., Yfantis, H. G., Tsai, Y. C., Williams, E. H., Lee, D. H., Stephens, R. M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004531 · Cited by 223
Pirola, L., Balcerczyk, A., Tothill, R. W., Haviv, I., Kaspi, A., Lunke, S., Ziemann, M., Karagiannis, T., Tonna, S., Kowalczyk, A., et al. (2011) · Genome Research · doi:10.1101/gr.116095.110 · Cited by 223
“could increase H3K9/K14 patterns (Lamb et al. 2006).”
DRUG-seq for miniaturized high-throughput transcriptome profiling in drug discovery
Ye, C., Ho, D. J., Neri, M., Yang, C., Kulkarni, T., Randhawa, R., Henault, M., Mostacci, N., Farmer, P., Renner, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06500-x · Cited by 222
Zhao, X., Psarianos, P., Ghoraie, L. S., Yip, K., Goldstein, D., Gilbert, R., Witterick, I., Pang, H., Hussain, A., Lee, J. H., et al. (2019) · Nature Metabolism · doi:10.1038/s42255-018-0008-5 · Cited by 222
Targeting CDK9 Reactivates Epigenetically Silenced Genes in Cancer
Zhang, H., Pandey, S., Travers, M., Sun, H., Morton, G., Madzo, J., Chung, W., Khowsathit, J., Perez-Leal, O., Barrero, C. A., et al. (2018) · Cell · doi:10.1016/j.cell.2018.09.051 · Cited by 222
DBTSS: database of transcription start sites, progress report 2008
Wakaguri, H., Yamashita, R., Suzuki, Y., Sugano, S., & Nakai, K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm901 · Cited by 222
Curcumin Inhibits Lung Cancer Cell Invasion and Metastasis through the Tumor Suppressor HLJ1
Chen, H.-W., Lee, J.-Y., Huang, J.-Y., Wang, C.-C., Chen, W.-J., Su, S.-F., Huang, C.-W., Ho, C.-C., Chen, J. J. W., Tsai, M.-F., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6734 · Cited by 221
Elucidating the Role of Gonadal Hormones in Sexually Dimorphic Gene Coexpression Networks
van Nas, A., GuhaThakurta, D., Wang, S. S., Yehya, N., Horvath, S., Zhang, B., Ingram-Drake, L., Chaudhuri, G., Schadt, E. E., Drake, T. A., et al. (2009) · Endocrinology · doi:10.1210/en.2008-0563 · Cited by 220
A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling
Yeakley, J. M., Shepard, P. J., Goyena, D. E., VanSteenhouse, H. C., McComb, J. D., & Seligmann, B. E. (2017) · PLOS ONE · doi:10.1371/journal.pone.0178302 · Cited by 219
Combining Drug and Gene Similarity Measures for Drug-Target Elucidation
Perlman, L., Gottlieb, A., Atias, N., Ruppin, E., & Sharan, R. (2011) · Journal of Computational Biology · doi:10.1089/cmb.2010.0213 · Cited by 218
“Expression-based: Gene expression responses to drugs were retrieved from the Connectivity Map project [44].”
Pham, T.-H., Qiu, Y., Zeng, J., Xie, L., & Zhang, P. (2021) · Nature Machine Intelligence · doi:10.1038/s42256-020-00285-9 · Cited by 217
Kunkel, S. D., Elmore, C. J., Bongers, K. S., Ebert, S. M., Fox, D. K., Dyle, M. C., Bullard, S. A., & Adams, C. M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039332 · Cited by 217
Integrative methods for analyzing big data in precision medicine
Gligorijević, V., Malod‐Dognin, N., & Pržulj, N. (2016) · PROTEOMICS · doi:10.1002/pmic.201500396 · Cited by 216
“…methods uses some notion of similarity between drugs (e.g. chemical similarity [149], similarity between gene expressions induced by drug actions [74], or drug side-effect similarity [150]) to group drugs and infer a novel drug candidate for repurposing from the group that can perform the same…”
MethodA genome-wide positioning systems network algorithm for in silico drug repurposing
Cheng, F., Lu, W., Liu, C., Fang, J., Hou, Y., Handy, D. E., Wang, R., Zhao, Y., Yang, Y., Huang, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10744-6 · Cited by 215
“We collected drug-gene signatures from the Connectivity Map (CMap, build 02) 23 .”
MethodReversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets
Chen, B., Ma, L., Paik, H., Sirota, M., Wei, W., Chua, M.-S., So, S., & Butte, A. J. (2017) · Nature Communications · doi:10.1038/ncomms16022 · Cited by 215
eXpression2Kinases (X2K) Web: linking expression signatures to upstream cell signaling networks
Clarke, D. J. B., Kuleshov, M. V., Schilder, B. M., Torre, D., Duffy, M. E., Keenan, A. B., Lachmann, A., Feldmann, A. S., Gundersen, G. W., Silverstein, M. C., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky458 · Cited by 215
“As part of the original X2K publication, a benchmark showed that the X2K pipeline can better identify drug targets when presenting the pipeline with signatures of drug-induced changes in gene expression from the original Connectivity Map database (8).”
MethodThe Emerging Paradigm of Network Medicine in the Study of Human Disease
Chan, S. Y., & Loscalzo, J. (2012) · Circulation Research · doi:10.1161/circresaha.111.258541 · Cited by 214
DrugNet: Network-based drug–disease prioritization by integrating heterogeneous data
Martínez, V., Navarro, C., Cano, C., Fajardo, W., & Blanco, A. (2015) · Artificial Intelligence in Medicine · doi:10.1016/j.artmed.2014.11.003 · Cited by 214
The Genomic Analysis of Lactic Acidosis and Acidosis Response in Human Cancers
Chen, J. L.-Y., Lucas, J. E., Schroeder, T., Mori, S., Wu, J., Nevins, J., Dewhirst, M., West, M., & Chi, J.-T. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000293 · Cited by 213
Mining gene expression profiles: expression signatures as cancer phenotypes
Nevins, J. R., & Potti, A. (2007) · Nature Reviews Genetics · doi:10.1038/nrg2137 · Cited by 211
Amorfrutins are potent antidiabetic dietary natural products
Weidner, C., de Groot, J. C., Prasad, A., Freiwald, A., Quedenau, C., Kliem, M., Witzke, A., Kodelja, V., Han, C.-T., Giegold, S., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1116971109 · Cited by 211
“Nevertheless, our in vitro results and detailed analyses of gene expression data, including application of the Connectivity Map approach (26) for drug discovery, strongly suggested that the amorfrutins act mainly as insulin sensitizers (SI Appendix, Table S2).”
BackgroundIdentifying blood biomarkers for mood disorders using convergent functional genomics
Le-Niculescu, H., Kurian, S. M., Yehyawi, N., Dike, C., Patel, S. D., Edenberg, H. J., Tsuang, M. T., Salomon, D. R., Nurnberger, J. I., & Niculescu, A. B. (2009) · Molecular Psychiatry · doi:10.1038/mp.2008.11 · Cited by 211
Withaferin A is a leptin sensitizer with strong antidiabetic properties in mice
Lee, J., Liu, J., Feng, X., Salazar Hernández, M. A., Mucka, P., Ibi, D., Choi, J. W., & Ozcan, U. (2016) · Nature Medicine · doi:10.1038/nm.4145 · Cited by 210
Role of artificial intelligence in revolutionizing drug discovery
Rehman, A. U., Li, M., Wu, B., Ali, Y., Rasheed, S., Shaheen, S., Liu, X., Luo, R., & Zhang, J. (2024) · Fundamental Research · doi:10.1016/j.fmre.2024.04.021 · Cited by 209
An omics perspective on drug target discovery platforms
Paananen, J., & Fortino, V. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbz122 · Cited by 207
Luo, H., Chen, J., Shi, L., Mikailov, M., Zhu, H., Wang, K., He, L., & Yang, L. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr299 · Cited by 206
“Five phenothiazine (chlorpromazine, fluphenazine, prochlorperazine, thioridazine and trifluoperazine) and two non-phenothiazine (haloperidol and clozapine) anti-psychotics showed positive connections in terms of gene expression profile (17).”
BackgroundMethodResultInfluentialYeh, C.-T., Wu, A. T. H., Chang, P. M.-H., Chen, K.-Y., Yang, C.-N., Yang, S.-C., Ho, C.-C., Chen, C.-C., Kuo, Y.-L., Lee, P.-Y., et al. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201207-1180oc · Cited by 206
Cao, J.-J., Tan, C.-P., Chen, M.-H., Wu, N., Yao, D.-Y., Liu, X.-G., Ji, L.-N., & Mao, Z.-W. (2017) · Chemical Science · doi:10.1039/c6sc02901a · Cited by 206
Mani, K. M., Lefebvre, C., Wang, K., Lim, W. K., Basso, K., Dalla‐Favera, R., & Califano, A. (2008) · Molecular Systems Biology · doi:10.1038/msb.2008.2 · Cited by 205
Triple-Negative Breast Cancer and the Potential for Targeted Therapy
Jhan, J.-R., & Andrechek, E. R. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0117 · Cited by 205
Large-scale chemical dissection of mitochondrial function
Wagner, B. K., Kitami, T., Gilbert, T. J., Peck, D., Ramanathan, A., Schreiber, S. L., Golub, T. R., & Mootha, V. K. (2008) · Nature Biotechnology · doi:10.1038/nbt1387 · Cited by 205
Self-citationAetiology of childhood leukaemia
Eden, T. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2010.02.004 · Cited by 204
Tumor-Associated Macrophages in the Cutaneous SCC Microenvironment Are Heterogeneously Activated
Pettersen, J. S., Fuentes-Duculan, J., Suárez-Fariñas, M., Pierson, K. C., Pitts-Kiefer, A., Fan, L., Belkin, D. A., Wang, C. Q. F., Bhuvanendran, S., Johnson-Huang, L. M., et al. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.9 · Cited by 203
Choose and Use Your Chemical Probe Wisely to Explore Cancer Biology
Blagg, J., & Workman, P. (2017) · Cancer Cell · doi:10.1016/j.ccell.2017.06.005 · Cited by 203
Bulusu, K. C., Guha, R., Mason, D. J., Lewis, R. P. I., Muratov, E., Kalantar Motamedi, Y., Cokol, M., & Bender, A. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2015.09.003 · Cited by 202
Omics Advances in Ecotoxicology
Zhang, X., Xia, P., Wang, P., Yang, J., & Baird, D. J. (2018) · Environmental Science & Technology · doi:10.1021/acs.est.7b06494 · Cited by 202
Xie, L., Xie, L., Kinnings, S. L., & Bourne, P. E. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134630 · Cited by 202
Drug repositioning and repurposing for Alzheimer disease
Ballard, C., Aarsland, D., Cummings, J., O’Brien, J., Mills, R., Molinuevo, J. L., Fladby, T., Williams, G., Doherty, P., Corbett, A., et al. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0397-4 · Cited by 201
Regulators of genetic risk of breast cancer identified by integrative network analysis
Castro, M. A. A., de Santiago, I., Campbell, T. M., Vaughn, C., Hickey, T. E., Ross, E., Tilley, W. D., Markowetz, F., Ponder, B. A. J., & Meyer, K. B. (2016) · Nature Genetics · doi:10.1038/ng.3458 · Cited by 201
An integrated platform of genomic assays reveals small-molecule bioactivities
Hoon, S., M Smith, A., Wallace, I. M., Suresh, S., Miranda, M., Fung, E., Proctor, M., Shokat, K. M., Zhang, C., Davis, R. W., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.100 · Cited by 201
Efficacy of Retinoids in IKZF1-Mutated BCR-ABL1 Acute Lymphoblastic Leukemia
Churchman, M. L., Low, J., Qu, C., Paietta, E. M., Kasper, L. H., Chang, Y., Payne-Turner, D., Althoff, M. J., Song, G., Chen, S.-C., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.07.016 · Cited by 200
Molecular Networks of Human Muscle Adaptation to Exercise and Age
Phillips, B. E., Williams, J. P., Gustafsson, T., Bouchard, C., Rankinen, T., Knudsen, S., Smith, K., Timmons, J. A., & Atherton, P. J. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003389 · Cited by 199
“This analysis has similarities to the Molecular Connectivity Database [86] where pre-existing collections of RNA signatures are compared with our lean-mass related gene list, and significant overlaps identified.”
ResultLagunin, A. A., Dubovskaja, V. I., Rudik, A. V., Pogodin, P. V., Druzhilovskiy, D. S., Gloriozova, T. A., Filimonov, D. A., Sastry, N. G., & Poroikov, V. V. (2018) · PLOS ONE · doi:10.1371/journal.pone.0191838 · Cited by 199
In silico polypharmacology of natural products
Fang, J., Liu, C., Wang, Q., Lin, P., & Cheng, F. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx045 · Cited by 199
Integrated multi-omics approaches to improve classification of chronic kidney disease
Eddy, S., Mariani, L. H., & Kretzler, M. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0286-5 · Cited by 198
Deep Learning for Genomics: From Early Neural Nets to Modern Large Language Models
Yue, T., Wang, Y., Zhang, L., Gu, C., Xue, H., Wang, W., Lyu, Q., & Dun, Y. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242115858 · Cited by 196
Wawer, M. J., Li, K., Gustafsdottir, S. M., Ljosa, V., Bodycombe, N. E., Marton, M. A., Sokolnicki, K. L., Bray, M.-A., Kemp, M. M., Winchester, E., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1410933111 · Cited by 196
“Unbiased profiling has been shown to capture the mechanistic details of a wide range of bioactivities (4, 5, 21) and we hypothesized it would assist in defining the composition of performance-diverse small-molecule libraries for cell-based screening.”
BackgroundSelf-citationHeterogeneity in Neutrophil Microparticles Reveals Distinct Proteome and Functional Properties
Dalli, J., Montero-Melendez, T., Norling, L. V., Yin, X., Hinds, C., Haskard, D., Mayr, M., & Perretti, M. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.028589 · Cited by 196
L1000FWD: fireworks visualization of drug-induced transcriptomic signatures
Wang, Z., Lachmann, A., Keenan, A. B., & Ma’ayan, A. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty060 · Cited by 195
“The newly generated LINCS L1000 data are a more comprehensive catalog of expression signatures than the original Connectivity Map (Lamb, 2006).”
MethodShared Molecular Neuropathology Across Major Psychiatric Disorders Parallels Polygenic Overlap
Gandal, M. J., Haney, J. R., Parikshak, N. N., Leppa, V., Ramaswami, G., Hartl, C., Schork, A. J., Appadurai, V., Buil, A., Werge, T. M., et al. (2019) · Focus · doi:10.1176/appi.focus.17103 · Cited by 195
Marquardt, J. U., Galle, P. R., & Teufel, A. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.07.007 · Cited by 195
“The Connectivity map is a publically available and powerful tool that enables discovery of functional connections between drugs and genes using a collection of genome-wide transcriptional expression data from cultured human cells treated with bioactive small molecules [39,40].”
BackgroundDrug-induced adverse events prediction with the LINCS L1000 data
Wang, Z., Clark, N. R., & Ma’ayan, A. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw168 · Cited by 195
Suárez-Fariñas, M., Lowes, M. A., Zaba, L. C., & Krueger, J. G. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010247 · Cited by 194
“This approach is successfully used in the Connectivity Map [27], a pattern recognition instance that correlates disease signatures (based on gene expression of any platform) with drugs.”
MethodSmith, I., Greenside, P. G., Natoli, T., Lahr, D. L., Wadden, D., Tirosh, I., Narayan, R., Root, D. E., Golub, T. R., Subramanian, A., et al. (2017) · PLOS Biology · doi:10.1371/journal.pbio.2003213 · Cited by 194
Self-citationWu, Y., & Wang, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082358 · Cited by 193
“Among the databases, CMap is the most popular one to analyze the relationship between transcriptome data and drugs [140].”
BackgroundPrediction of drug efficacy from transcriptional profiles with deep learning
Zhu, J., Wang, J., Wang, X., Gao, M., Guo, B., Gao, M., Liu, J., Yu, Y., Wang, L., Kong, W., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-021-00946-z · Cited by 193
Targeting breast cancer stem cells
McDermott, S. P., & Wicha, M. S. (2010) · Molecular Oncology · doi:10.1016/j.molonc.2010.06.005 · Cited by 193
High-throughput phenotyping of lung cancer somatic mutations
Berger, A. H., Brooks, A. N., Wu, X., Shrestha, Y., Chouinard, C., Piccioni, F., Bagul, M., Kamburov, A., Imielinski, M., Hogstrom, L., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.06.022 · Cited by 192
Self-citationHDAC inhibitors induce tumor-cell-selective pro-apoptotic transcriptional responses
Bolden, J. E., Shi, W., Jankowski, K., Kan, C.-Y., Cluse, L., Martin, B. P., MacKenzie, K. L., Smyth, G. K., & Johnstone, R. W. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.9 · Cited by 192
Zimmer, M., Ebert, B. L., Neil, C., Brenner, K., Papaioannou, I., Melas, A., Tolliday, N., Lamb, J., Pantopoulos, K., Golub, T., et al. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.12.004 · Cited by 191
Self-citationRole of the ERO1-PDI interaction in oxidative protein folding and disease
Shergalis, A. G., Hu, S., Bankhead, A., & Neamati, N. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107525 · Cited by 190
Neuro-symbolic representation learning on biological knowledge graphs
Alshahrani, M., Khan, M. A., Maddouri, O., Kinjo, A. R., Queralt-Rosinach, N., & Hoehndorf, R. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx275 · Cited by 150
An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation
Vo, A. H., Van Vleet, T. R., Gupta, R. R., Liguori, M. J., & Rao, M. S. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00227 · Cited by 188
A comprehensive review of feature based methods for drug target interaction prediction
Sachdev, K., & Gupta, M. K. (2019) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2019.103159 · Cited by 187
Predicting Drug–Target Interactions Using Probabilistic Matrix Factorization
Cobanoglu, M. C., Liu, C., Hu, F., Oltvai, Z. N., & Bahar, I. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci400219z · Cited by 187
Nickeleit, I., Zender, S., Sasse, F., Geffers, R., Brandes, G., Sörensen, I., Steinmetz, H., Kubicka, S., Carlomagno, T., Menche, D., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.05.016 · Cited by 187
High-Throughput Transcriptomics Platform for Screening Environmental Chemicals
Harrill, J. A., Everett, L. J., Haggard, D. E., Sheffield, T., Bundy, J. L., Willis, C. M., Thomas, R. S., Shah, I., & Judson, R. S. (2021) · Toxicological Sciences · doi:10.1093/toxsci/kfab009 · Cited by 186
Ljosa, V., Caie, P. D., ter Horst, R., Sokolnicki, K. L., Jenkins, E. L., Daya, S., Roberts, M. E., Jones, T. R., Singh, S., Genovesio, A., et al. (2013) · SLAS Discovery · doi:10.1177/1087057113503553 · Cited by 186
Self-citationLi, J., Zhu, X., & Chen, J. Y. (2009) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000450 · Cited by 185
Hassane, D. C., Guzman, M. L., Corbett, C., Li, X., Abboud, R., Young, F., Liesveld, J. L., Carroll, M., & Jordan, C. T. (2008) · Blood · doi:10.1182/blood-2007-11-126003 · Cited by 185
IgG1 memory B cells keep the memory of IgE responses
He, J.-S., Subramaniam, S., Narang, V., Srinivasan, K., Saunders, S. P., Carbajo, D., Wen-Shan, T., Hidayah Hamadee, N., Lum, J., Lee, A., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00723-0 · Cited by 185
MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer
Hudson, R. S., Yi, M., Esposito, D., Watkins, S. K., Hurwitz, A. A., Yfantis, H. G., Lee, D. H., Borin, J. F., Naslund, M. J., Alexander, R. B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr1222 · Cited by 184
Nowak-Sliwinska, P., Scapozza, L., & Ruiz i Altaba, A. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.04.005 · Cited by 183
Wei, G., Margolin, A. A., Haery, L., Brown, E., Cucolo, L., Julian, B., Shehata, S., Kung, A. L., Beroukhim, R., & Golub, T. R. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.028 · Cited by 183
“org/ cmap) (Lamb et al., 2006), the triptolide-induced profile showed a high degree of similarity to both doxorubicin and daunorubicin (ranked 1 and 2 of 1,366, respectively, using Spearman correlation) (Figure 1D).”
MethodResultSelf-citationA review of connectivity map and computational approaches in pharmacogenomics
Musa, A., Ghoraie, L. S., Zhang, S.-D., Glazko, G., Yli-Harja, O., Dehmer, M., Haibe-Kains, B., & Emmert-Streib, F. (2017) · Briefings in Bioinformatics · doi:10.1093/bib/bbx023 · Cited by 149
Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
Du, W., & Elemento, O. (2015) · Oncogene · doi:10.1038/onc.2014.291 · Cited by 182
TAM 2.0: tool for MicroRNA set analysis
Li, J., Han, X., Wan, Y., Zhang, S., Zhao, Y., Fan, R., Cui, Q., & Zhou, Y. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky509 · Cited by 182
Parallel shRNA and CRISPR-Cas9 screens enable antiviral drug target identification
Deans, R. M., Morgens, D. W., Ökesli, A., Pillay, S., Horlbeck, M. A., Kampmann, M., Gilbert, L. A., Li, A., Mateo, R., Smith, M., et al. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2050 · Cited by 182
Wang, N., Zheng, J., Chen, Z., Liu, Y., Dura, B., Kwak, M., Xavier-Ferrucio, J., Lu, Y.-C., Zhang, M., Roden, C., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-07981-6 · Cited by 181
Zhou, Y., Hou, Y., Shen, J., Mehra, R., Kallianpur, A., Culver, D. A., Gack, M. U., Farha, S., Zein, J., Comhair, S., et al. (2020) · PLoS Biology · doi:10.1371/journal.pbio.3000970 · Cited by 180
High-Throughput Methods in the Discovery and Study of Biomaterials and Materiobiology
Yang, L., Pijuan-Galito, S., Rho, H. S., Vasilevich, A. S., Eren, A. D., Ge, L., Habibović, P., Alexander, M. R., de Boer, J., Carlier, A., et al. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00752 · Cited by 180
Metadata
- Authors
- Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., Reich, M., Hieronymus, H., Wei, G., Armstrong, S. A., Haggarty, S. J., Clemons, P. A., Wei, R., Carr, S. A., Lander, E. S., & Golub, T. R.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Lamb, Justin
- Crawford, Emily D.
- Golub, Todd R.
- ORCID
- Venue
- Science
- Published
- 2006-09-29
- Volume
- 313
- Issue
- 5795
- Pages
- 1929-1935
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2121604817
- Cited by
- 5,257
- References
- 41
- Citations by year
- 2026: 226 · 2025: 285 · 2024: 332 · 2023: 370 · 2022: 416 · 2021: 406 · 2020: 383 · 2019: 385 · 2018: 280 · 2017: 288 · 2016: 296 · 2015: 259 · 2014: 217 · 2013: 241 · 2012: 219
- FWCI
- 118.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gene expression and cancer classification
- Keywords
- Connectivity Map, gene expression signatures, small molecules, drug action, gene perturbation, mechanism of action, cultured human cells, functional genomics
- MeSH terms
- Alzheimer Disease, Cell Line, Dexamethasone, Drug Evaluation, Preclinical, Enzyme Inhibitors, Estrogens, Humans, Obesity, Phenothiazines, Software, Gene Expression, Databases, Factual, HSP90 Heat-Shock Proteins, Drug Resistance, Neoplasm, Sirolimus, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Limonins, Cell Line, Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Histone Deacetylase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.